✦ LIBER ✦

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion

✍ Scribed by Hikichi, T.; Higuchi, M.; Matsushita, T.; Kosaka, S.; Matsushita, R.; Takami, K.; Ohtsuka, H.; Kitamei, H.; Shioya, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravitreal bevacizumab for macular oed

✍ Gündüz, K; Bakri, S J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

Intravitreal bevacizumab for macular oed

✍ Hu, K; Horgan, S E; Sivaraj, R R; Avgikos, K 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 51 KB

One-year results after intravitreal beva

✍ Gesine B. Jaissle; Martin Leitritz; Faik Gelisken; Focke Ziemssen; Karl Ulrich B 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 257 KB

Intravitreal triamcinolone acetonide vs

✍ Cheng, K-C; Wu, W-C; Chen, K-J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 419 KB

Intravitreal bevacizumab treatment of ma

✍ Spandau, Ulrich H. M. ;Ihloff, Anna K. ;Jonas, Jost B. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

Intravitreal bevacizumab vs triamcinolon

✍ Tao, Y; Hou, J; Jiang, Y-R; Li, X-X; Jonas, J B 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB